Alkem Laboratories Limited
NSE:ALKEM.NS
Overview | Financials
Company Name | Alkem Laboratories Limited |
Symbol | ALKEM.NS |
Currency | INR |
Price | 5,706.5 |
Market Cap | 682,297,672,500 |
Dividend Yield | 0.85% |
52-week-range | 4,212.5 - 6,439.9 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Basudeo Narian Singh |
Website | https://www.alkemlabs.com |
An error occurred while fetching data.
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD